Q2 2024 13F Holders as of 6/30/2024
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
87.5M
-
Number of holders
-
173
-
Total 13F shares, excl. options
-
80.5M
-
Shares change
-
-185K
-
Total reported value, excl. options
-
$1.66B
-
Value change
-
-$4.36M
-
Put/Call ratio
-
0.43
-
Number of buys
-
81
-
Number of sells
-
-78
-
Price
-
$20.59
Significant Holders of Kura Oncology, Inc. - Common Stock (KURA) as of Q2 2024
203 filings reported holding KURA - Kura Oncology, Inc. - Common Stock as of Q2 2024.
Kura Oncology, Inc. - Common Stock (KURA) has 173 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 80.5M shares
of 87.5M outstanding shares and own 91.96% of the company stock.
Largest 10 shareholders include SUVRETTA CAPITAL MANAGEMENT, LLC (7.07M shares), BlackRock Inc. (6.97M shares), EcoR1 Capital, LLC (5.81M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (5.41M shares), Paradigm Biocapital Advisors LP (4.54M shares), BVF INC/IL (4.08M shares), VANGUARD GROUP INC (4.04M shares), Avoro Capital Advisors LLC (3.54M shares), STATE STREET CORP (2.88M shares), and Holocene Advisors, LP (2.69M shares).
This table shows the top 173 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.